ALFA FinderBSE filing, NSE: ENNATURE. Summary written from the filing by ALFA Finder's alert engine.
Ennature Bio Pharma Ltd: key numbers
- Share price
- ₹201.70
- Market cap
- ₹450.6 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.00 Cr
- Promoter holding
- 59.63%
- FII holding
- 2.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ennature Bio Pharma Ltd
All →Ennature Bio Pharma Other Announcement
Ennature Bio Pharma designated five senior managers (Heads/DGMs) as SMP per SEBI circular. This is a routine compliance intimation with no material business impact.
Ennature Bio Pharma Q2 FY27 Results: Turns Profitable, Net Profit ₹4.9 Cr
Ennature Bio Pharma Ltd reported revenue from operations of ₹78.5 Cr (+45.1% YoY) and net profit of ₹4.9 Cr for Q2 FY27.
- Key figure
- Net profit ₹4.9 Cr
Ennature Bio Pharma Board Meeting Date
Ennature Bio Pharma will hold a board meeting on 12 November 2026 to consider unaudited second-quarter results ended September 2026. Trading window stays closed until 14 November.
Ennature Bio Pharma Capital Structure Change
Ennature Bio Pharma listed its equity shares on NSE and BSE on 4 November 2026. The company brings its API, biopolymer and nutraceutical businesses to public markets.
Other board meeting outcome announcements
All →Shri Keshav Cements & Infra Board Meeting Outcome
Shri Keshav Cements' board approved un-audited financial and segment-wise revenue results for the quarter and half-year ended 30 September 2026. No other material decisions were transacted.
Balmer Lawrie Investments Board Meeting Outcome
Balmer Lawrie Investments appointed M/s. K. K. Chanani & Associates as Statutory Auditor for FY 2026-27 under Section 139(5), per a C&AG letter. The appointment is effective from 10 November 2026.
- Execution
- FY 2026-27
Jiwanram Sheoduttrai Industries Board Meeting Outcome
Jiwanram Sheoduttrai's board approved convening its 29th AGM on 30 November 2026 and re-appointing a retiring non-executive director. The board also approved the FY2025-26 Board's Report.
Finolex Cables Board Meeting Outcome
Finolex Cables' board approved amending its insider trading code of conduct on 7 November 2026. Amended code was filed under PIT Regulation 8(2).
Chatterbox Technologies Board Meeting Outcome
Chatterbox's board approved a Rs. 7 crore related-party ceiling with its UAE subsidiary and a vendor change for IPO funds. Monitoring agency and deviation reports were also noted.
BCC Fuba India Board Meeting Outcome
BCC Fuba India's board met on November 6, 2026 and took note of consolidated related party transactions for the half year ended September 30, 2026. No financial results, capital raise or other material decision was reported.